BB Biotech AG (BION.S)
22 Dec 2014
|Market Cap (Mil.):||CHF2,832.15|
|Shares Outstanding (Mil.):||11.85|
ZURICH, Nov 17 - Activist investor Elliott Management Corp has become the second largest shareholder in Switzerland's BB Biotech, an investment firm with holdings in about 30 biotech companies.
* Says net asset value rose 21.2 percent in swiss francs in Q3
July 17 - BB Biotech AG : * Says net asset value (NAV) has increased 13.2% in usd, 12.5% in chf and 13.7%
Earnings vs. Estimates
Analyst Research Reports
BB Biotech AG: Business description, financial summary, 3yr and interim financials, key statistics/ratios and historical ratio analysis.
Provider: Reuters Investment Profile
NYSE and AMEX quotes delayed by at least 20 minutes. NASDAQ delayed by at least 15 minutes. For a complete list of exchanges and delays, please click here.